23andMe Holding Co. (ME)
USD 3.14
(-3.09%)
USD 3.14
(-3.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -666.7 Million USD | -113.92% |
| 2022 | -311.65 Million USD | -43.3% |
| 2021 | -217.49 Million USD | -18.61% |
| 2020 | -183.36 Million USD | 36.62% |
| 2019 | -289.31 Million USD | -57.63% |
| 2018 | -183.53 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -69.4 Million USD | 66.77% |
| 2023 Q4 | -208.83 Million USD | 24.87% |
| 2023 Q2 | -75.27 Million USD | 28.06% |
| 2023 FY | -666.7 Million USD | -113.92% |
| 2023 Q3 | -277.97 Million USD | -269.31% |
| 2023 Q1 | -104.62 Million USD | -63.23% |
| 2022 Q4 | -64.09 Million USD | 30.3% |
| 2022 Q3 | -91.96 Million USD | -39.2% |
| 2022 Q2 | -66.06 Million USD | 26.21% |
| 2022 Q1 | -89.53 Million USD | -28.74% |
| 2022 FY | -311.65 Million USD | -43.3% |
| 2021 Q3 | -89.39 Million USD | -441.01% |
| 2021 FY | -217.49 Million USD | -18.61% |
| 2021 Q4 | -69.54 Million USD | 22.21% |
| 2021 Q2 | -16.52 Million USD | 60.68% |
| 2021 Q1 | -42.02 Million USD | 37.29% |
| 2020 Q4 | -67.01 Million USD | -50.1% |
| 2020 FY | -183.36 Million USD | 36.62% |
| 2020 Q3 | -44.64 Million USD | -23.36% |
| 2020 Q2 | -36.19 Million USD | -1.18% |
| 2020 Q1 | -35.77 Million USD | 0.0% |
| 2019 FY | -289.31 Million USD | -57.63% |
| 2018 FY | -183.53 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | -186.763% |
| Prenetics Global Limited | -62.72 Million USD | -962.919% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -42968.734% |
| CareDx, Inc | -190.28 Million USD | -250.373% |
| Exact Sciences Corporation | -204.14 Million USD | -226.577% |
| Exagen Inc. | -23.68 Million USD | -2714.403% |
| Inotiv, Inc. | -105.14 Million USD | -534.111% |
| Guardant Health, Inc. | -479.44 Million USD | -39.056% |
| Biodesix, Inc. | -52.14 Million USD | -1178.533% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -25259.19% |
| Precipio, Inc. | -5.85 Million USD | -11290.808% |
| iSpecimen Inc. | -11.09 Million USD | -5906.619% |
| Natera, Inc. | -434.8 Million USD | -53.335% |
| Aspira Women's Health Inc. | -16.69 Million USD | -3894.632% |
| Standard BioTools Inc. | -74.65 Million USD | -793.035% |
| Castle Biosciences, Inc. | -57.46 Million USD | -1060.171% |
| Personalis, Inc. | -108.29 Million USD | -515.631% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -653.5% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -6602.524% |
| OpGen, Inc. | -32.66 Million USD | -1940.814% |
| T2 Biosystems, Inc. | -50.07 Million USD | -1231.358% |
| Myriad Genetics, Inc. | -112 Million USD | -495.271% |
| ICON Public Limited Company | 612.33 Million USD | 208.879% |
| NeoGenomics, Inc. | -87.96 Million USD | -657.894% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -42968.734% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 178.896% |
| RadNet, Inc. | 3.04 Million USD | 22002.234% |
| MDxHealth SA | -43.1 Million USD | -1446.877% |
| Psychemedics Corporation | -4.15 Million USD | -15949.687% |
| Illumina, Inc. | -1.16 Billion USD | 42.575% |
| Check-Cap Ltd. | -17.56 Million USD | -3694.991% |
| Twist Bioscience Corporation | -208.72 Million USD | -219.416% |
| DarioHealth Corp. | -59.42 Million USD | -1021.887% |
| Fulgent Genetics, Inc. | -167.82 Million USD | -297.261% |
| Sera Prognostics, Inc. | -36.24 Million USD | -1739.589% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -6527.112% |
| OPKO Health, Inc. | -188.86 Million USD | -253.009% |
| Medpace Holdings, Inc. | 282.81 Million USD | 335.743% |
| Neogen Corporation | -9.42 Million USD | -6976.786% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -6464.141% |
| Prenetics Global Limited | -62.72 Million USD | -962.919% |
| Mainz Biomed B.V. | -26.29 Million USD | -2435.408% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -8299.938% |
| Trinity Biotech plc | -24.01 Million USD | -2675.851% |
| Neuronetics, Inc. | -30.18 Million USD | -2108.434% |
| Sotera Health Company | 51.37 Million USD | 1397.695% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -8299.938% |